Cyclopentanamine

Cyclopentanamine

SCHEMBL27699239

C#N.NC1CCCC1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclohexylamine SCHEMBL27947339 0.96 — —
Cyclooctanamine SCHEMBL27758196 0.96 THRB (0.41) —
Cyanide SCHEMBL28137722 0.88 — —
Cyanide SCHEMBL21222855 0.88 — —
Cyclopentanamine SCHEMBL9222 0.88 — —
SCHEMBL14665759 0.88 THRB (0.54) —
Cyclohexylamine SCHEMBL25428096 0.85 — —
SCHEMBL23379889 0.84 THRB (0.50) —
SCHEMBL20830445 0.84 THRB (0.50) —
SCHEMBL23379885 0.84 THRB (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108276389-B Synthetic method of irbesartan 北京化工大学 2020-10-16 — — CN disclosed
CN-101014578-B Triazole derivative or salt thereof ASTELLAS PHARMA INC 2011-01-19 — — CN disclosed
CN-101605798-A Imidazothiazole derivative DAIICHI SANKYO CO LTD (JP) 2009-12-16 — — CN disclosed
CN-101365680-A 3, 5-substituted piperidine compounds as renin inhibitors NOVARTIS AG (CH) 2009-02-11 — — CN disclosed
CN-101014578-A Triazole derivative or salt thereof ASTELLAS PHARMA INC (JP) 2007-08-08 — — CN disclosed
Send feedback